| Aspirin prevents TNF-α-induced endothelial cell dysfunction by regulating the NF-κB-dependent miR-155/eNOS pathway: Role of a miR-155/eNOS axis in preeclampsia J Kim, KS Lee, JH Kim, DK Lee, M Park, S Choi, W Park, S Kim, YK Choi, ... Free Radical Biology and Medicine 104, 185-198, 2017 | 129 | 2017 |
| Functional role of NF-κB in expression of human endothelial nitric oxide synthase KS Lee, J Kim, SN Kwak, KS Lee, DK Lee, KS Ha, MH Won, D Jeoung, ... Biochemical and Biophysical Research Communications 448 (1), 101-107, 2014 | 105 | 2014 |
| Hypoxia-Responsive MicroRNA-101 Promotes Angiogenesis via Heme Oxygenase-1/Vascular Endothelial Growth Factor Axis by Targeting Cullin 3 JH Kim, KS Lee, DK Lee, J Kim, SN Kwak, KS Ha, J Choe, MH Won, ... Antioxidants & redox signaling 21 (18), 2469-2482, 2014 | 103 | 2014 |
| NF-κB–responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase S Kim, KS Lee, S Choi, J Kim, DK Lee, M Park, W Park, TH Kim, ... Journal of Biological Chemistry 293 (49), 18989-19000, 2018 | 80 | 2018 |
| Carbon monoxide prevents TNF-α-induced eNOS downregulation by inhibiting NF-κB-responsive miR-155-5p biogenesis S Choi, J Kim, JH Kim, DK Lee, W Park, M Park, S Kim, JY Hwang, ... Experimental & molecular medicine 49 (11), e403-e403, 2017 | 51 | 2017 |
| TNF-α elicits phenotypic and functional alterations of vascular smooth muscle cells by miR-155-5p–dependent down-regulation of cGMP-dependent kinase 1 S Choi, M Park, J Kim, W Park, S Kim, DK Lee, JY Hwang, J Choe, ... Journal of Biological Chemistry 293 (38), 14812-14822, 2018 | 49 | 2018 |
| NF-κB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase M Park, S Choi, S Kim, J Kim, DK Lee, W Park, T Kim, J Jung, JY Hwang, ... Experimental & molecular medicine 51 (2), 1-12, 2019 | 41 | 2019 |
| Metabolic Control of m6A RNA Modification J Kim, G Lee Metabolites 11 (2), 80, 2021 | 39 | 2021 |
| Novel hypoxia-inducible factor 1α (HIF-1α) inhibitors for angiogenesis-related ocular diseases: discovery of a novel scaffold via ring-truncation strategy H An, S Lee, JM Lee, DH Jo, J Kim, YS Jeong, MJ Heo, CS Cho, H Choi, ... Journal of Medicinal Chemistry 61 (20), 9266-9286, 2018 | 35 | 2018 |
| Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors HS Kim, M Hong, SC Lee, HY Lee, YG Suh, DC Oh, JH Seo, H Choi, ... European journal of medicinal chemistry 104, 157-164, 2015 | 31 | 2015 |
| REDD‐1 aggravates endotoxin‐induced inflammation VIA atypical NF‐κB activation DK Lee, JH Kim, J Kim, S Choi, MS Park, W Park, S Kim, KS Lee, T Kim, ... The FASEB Journal 32 (8), 4585-4599, 2018 | 30 | 2018 |
| Synthesis and biological evaluation of C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors HS Kim, M Hong, J Ann, S Yoon, CT Nguyen, SC Lee, HY Lee, YG Suh, ... Bioorganic & Medicinal Chemistry 24 (22), 6082-6093, 2016 | 29 | 2016 |
| Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism YY Baek, DK Lee, J Kim, JH Kim, W Park, T Kim, S Han, D Jeoung, ... Oncotarget 8 (7), 11763, 2017 | 17 | 2017 |
| REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation DK Lee, T Kim, J Byeon, M Park, S Kim, J Kim, S Choi, G Lee, C Park, ... Nature communications 13 (1), 6303, 2022 | 13 | 2022 |
| NF-κB-dependent miR-31/155 biogenesis is essential for TNF-α-induced impairment of endothelial progenitor cell function JH Kim, JY Kim, M Park, S Kim, T Kim, J Kim, S Choi, W Park, JY Hwang, ... Experimental & Molecular Medicine 52 (8), 1298-1309, 2020 | 13 | 2020 |
| REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expression M Park, J Kim, T Kim, S Kim, W Park, KS Ha, SH Cho, MH Won, JH Lee, ... Experimental & Molecular Medicine 53 (10), 1612-1622, 2021 | 11 | 2021 |
| Low-dose metronomic doxorubicin inhibits mobilization and differentiation of endothelial progenitor cells through REDD1-mediated VEGFR-2 downregulation M Park, JY Kim, J Kim, JH Lee, YG Kwon, YM Kim BMB reports 54 (9), 470, 2021 | 11 | 2021 |
| N-Terminal modification of the tetrapeptide Arg-Leu-Tyr-Glu, a vascular endothelial growth factor receptor-2 (VEGFR-2) antagonist, improves antitumor activity by increasing its … JA Yun, J Kim, YY Baek, W Park, M Park, S Kim, T Kim, S Choi, D Jeoung, ... Molecular pharmacology 96 (6), 692-701, 2019 | 11 | 2019 |
| MAPK13 stabilization via m6A modification limits anti-cancer efficacy of rapamycin J Kim, Y Chun, CB Ramirez, LA Hoffner, S Jung, KH Jang, VI Rubtsova, ... bioRxiv, 2022.08. 05.502726, 2022 | | 2022 |
